ProMedicus (ASX:PME)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ProMedicus.
RELATED STOCKHEAD STORIES
Health Check: For ASX biotechs, the business of America remains business
EchoSolv enters Mayo’s test zone as it chases FDA approval
Scott Power: ASX health lifts to start FY26, Tetratherix ends IPO drought
Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Lunch Wrap: ASX takes profits as GemLife pops on IPO debut, Santa Fe surges 300pc
Health Check: And the EOFY biotech winner is … gasp … a pot stock
Closing Bell: Healthcare sector gives ASX a booster to rise 0.33pc
Health Check: Don’t dis-May! ASX biotechs record strong year-on-year share gains
Lunch Wrap: ASX back to the grind after US Fed rate hold; Locksley doubles on US rare earths hunt
Health Check: Investors catch a falling knife as biotech big names bounce from lows
ASX health April winners: Sector rises 2pc in stronger month for markets
Scott Power: ASX health sector down in week of good and bad news
Scott Power: ASX health stocks feel force of market volatility
